Pharmedic Pharmaceutical Medicinal JSC (HNX:PMC)
Vietnam · Delayed Price · Currency is VND 116,900
-3,000 (-2.50%)
At close: Aug 28, 2026
HNX:PMC Ratios and Metrics
Market cap in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,090,978 | 1,541,741 | 970,588 | 803,535 | 793,269 | 611,284 | |
Market Cap Growth | 12.40% | 58.85% | 20.79% | 1.29% | 29.77% | 13.91% |
Enterprise Value | 1,144,781 | 1,509,383 | 739,173 | 475,122 | 508,725 | 375,105 |
Last Close Price | 116900.00 | 160893.74 | 91804.77 | 67401.86 | 55396.74 | 41125.61 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 21.24 | 25.66 | 16.59 | 13.17 | 13.03 | 12.93 |
PS Ratio | 2.00 | 2.82 | 1.95 | 1.66 | 1.68 | 1.48 |
PB Ratio | 4.32 | 6.40 | 3.35 | 2.34 | 1.85 | 1.57 |
P/TBV Ratio | 4.60 | 6.46 | 3.38 | 2.36 | 1.87 | 1.58 |
P/FCF Ratio | - | - | 24.74 | 9.27 | 25.04 | 10.38 |
P/OCF Ratio | 296.33 | 74.45 | 17.98 | 8.49 | 21.44 | 9.73 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 2.10 | 2.76 | 1.48 | 0.98 | 1.08 | 0.91 |
EV/EBITDA Ratio | 10.59 | 13.75 | 7.25 | 4.93 | 4.92 | 4.33 |
EV/EBIT Ratio | 12.41 | 15.42 | 8.17 | 5.63 | 5.61 | 5.17 |
EV/FCF Ratio | - | - | 18.84 | 5.48 | 16.06 | 6.37 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.34 | 0.00 | - | - | - | - |
Debt / EBITDA Ratio | 0.80 | 0.00 | - | - | - | - |
Net Debt / Equity Ratio | 0.21 | -0.17 | -0.69 | -0.76 | -0.69 | -0.70 |
Net Debt / EBITDA Ratio | 0.50 | -0.37 | -1.97 | -2.72 | -2.84 | -3.14 |
Net Debt / FCF Ratio | -0.72 | 0.69 | -5.13 | -3.03 | -9.27 | -4.61 |
Asset Turnover | 1.41 | 1.52 | 1.24 | 1.05 | 1.00 | 0.94 |
Inventory Turnover | 2.45 | 3.70 | 4.50 | 3.67 | 3.25 | 3.32 |
Quick Ratio | 0.54 | 0.72 | 2.85 | 3.67 | 5.01 | 5.00 |
Current Ratio | 1.70 | 2.10 | 3.89 | 4.56 | 6.65 | 6.21 |
Return on Equity (ROE) | 28.83% | 31.03% | 25.33% | 21.68% | 20.43% | 17.20% |
Return on Assets (ROA) | 14.83% | 16.97% | 14.10% | 11.46% | 12.00% | 10.30% |
Return on Invested Capital (ROIC) | 25.62% | 54.23% | 85.30% | 62.68% | 57.62% | 45.36% |
Return on Capital Employed (ROCE) | 36.50% | 40.60% | 31.20% | 24.60% | 21.20% | 18.70% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 4.71% | 5.34% | 8.26% | 10.40% | 10.52% | 10.59% |
FCF Yield | -6.85% | -3.82% | 4.04% | 10.79% | 3.99% | 9.63% |
Dividend Yield | 1.89% | - | 2.61% | 28.34% | 5.42% | 5.84% |
Payout Ratio | 79.28% | 131.78% | 137.95% | 164.60% | 27.30% | 33.44% |
Total Shareholder Return | 1.89% | - | 2.61% | 28.34% | 5.42% | 5.84% |